Treatment Response Assessment According to Updated PROMISE Criteria in Patients with Metastatic Prostate Cancer Using an Automated Imaging Platform for Identification, Measurement, and Temporal Tracking of Disease

By sjmartinez • November 14, 2024

Benitez CM, Sahlstedt H, Sonni I, Brynolfsson J, Berenji GR, Juarez JE, Kane N, Tsai S, Rettig M, Nickols NG, Duriseti S. Treatment Response Assessment According to Updated PROMISE Criteria in Patients with Metastatic Prostate Cancer Using an Automated Imaging Platform for Identification, Measurement, and Temporal Tracking of Disease. Eur Urol Oncol. 2024 Nov 8:S2588-9311(24)00240-2. doi: 10.1016/j.euo.2024.10.011. Epub ahead of print. PMID: 39521638.

Tags: Artificial intelligence, Automated, Hematology/Oncology, Positron emission tomography, prostate-specific membrane antigen, Publications, Veterans Administration

Iron Deficiency Anemia in Children During and After PICU Stay: Single-Center Retrospective Cohort, 2021-2022

Vadivelan A, Nemeth E, Ganz T, Bulut Y. Iron Deficiency Anemia in Children During and After PICU Stay: Single-Center Retrospective Cohort, 2021-2022. Pediatr Crit Care[...]

Plasma Protein Biomarkers for the Cognitive Functions in Women Living with HIV

Li W, Rubin LH, Xu YH, Wang G, Li D, Vance DE. Plasma Protein Biomarkers for the Cognitive Functions in Women Living with HIV. Alzheimers[...]

RE: Enhancing Capacity for Primary Care Research in Cancer Survivorship: National Cancer Institute Meeting Report

McClellan SP, Rivera-Avila DA, Cardenas E, Pérez-Zepeda MU, Dykens JA, Weine SM, Fitzgibbon M, Ganz P, García-Peña C. RE: Enhancing Capacity for Primary Care Research[...]